Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Efficacy and Safety of Oral Febuxostat in Participants With Gout [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of oral febuxostat in participants with gout has completed, with results posted in July 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2009-07-16